title: Review: bDMARDs are linked to increased risk for infection compared with conventional synthetic DMARDs in RA.
authors.forename: Ami
authors.initials: A
authors.lastname: Schattner
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000009:adverse effects*; D006801:Humans
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products